Cargando…

Characterization of atrial histology in a patient with hypertrophic cardiomyopathy: Possible evidence of a primary atrial myopathy

Detalles Bibliográficos
Autores principales:	Keane, Stephen, Fabre, Aurelie, Keane, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226312/ https://www.ncbi.nlm.nih.gov/pubmed/34194992 http://dx.doi.org/10.1016/j.hrcr.2021.03.017

Ejemplares similares

Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Review
por: Palyam, Vishnu, et al.
Publicado: (2022)

Swallowing-induced atrial tachycardia in an adolescent with hypertrophic cardiomyopathy: a case report
por: Challapudi, Geetha, et al.
Publicado: (2017)

Transient swallowing‐induced atrial tachycardia in a patient with genotyped hypertrophic cardiomyopathy
por: Fujino, Noboru, et al.
Publicado: (2020)

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Papavassiliu, Theano, et al.
Publicado: (2009)

Left atrial remodeling and mechanical dysfunction in hypertrophic cardiomyopathy
por: Kim, Kyung-Jin, et al.
Publicado: (2016)

Atrial Function Assessment in High-Risk Hypertrophic Cardiomyopathy
por: Mulia, Eka Prasetya Budi, et al.
Publicado: (2023)

Multimodality Imaging in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2023)

Atrial Myopathy
por: Shen, Mark J., et al.
Publicado: (2019)

Surgical and transcatheter left atrial appendage closure in patients with atrial fibrillation and hypertrophic cardiomyopathy
por: Khawaja, Tasveer, et al.
Publicado: (2023)

Anesthetic management of a patient with hypertrophic cardiomyopathy with atrial flutter posted for percutaneous nephrolithotomy
por: Nama, Rajnish K., et al.
Publicado: (2015)

Atrial Myopathy Underlying Atrial Fibrillation
por: Rivner, Harold, et al.
Publicado: (2020)

Left Atrial Appendage Closure for Primary and Secondary Stroke Prevention in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Pilot Study
por: Mo, Bin-Feng, et al.
Publicado: (2021)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
por: Park, Kyoung-min, et al.
Publicado: (2016)

Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation
por: Tian, Hongwei, et al.
Publicado: (2018)

Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy
por: Kim, Kyung-Jin, et al.
Publicado: (2016)

Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2020)

State-of-the-Art Treatments for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
por: Penela, Diego, et al.
Publicado: (2021)

Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022)

Right Ventricular and Right Atrial Involvement Can Predict Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy?
por: Doesch, Christina, et al.
Publicado: (2016)

Radiofrequency catheter ablation is effective for atrial fibrillation patients with hypertrophic cardiomyopathy by decreasing left atrial pressure
por: Ikenaga, Hiroki, et al.
Publicado: (2017)

Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy
por: Nedios, Sotirios, et al.
Publicado: (2021)

Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
por: An, Myeonghyun, et al.
Publicado: (2023)

Combined ablation for paroxysmal atrial fibrillation and drug-refractory hypertrophic obstructive cardiomyopathy: a case report
por: Akita, Keitaro, et al.
Publicado: (2021)

Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Rozen, Guy, et al.
Publicado: (2020)

Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Semper Discere (Always Learning)
por: Estes, N. A. Mark, et al.
Publicado: (2021)

Clinical significance of new‐onset atrial fibrillation in patients with hypertrophic cardiomyopathy
por: Kubo, Toru, et al.
Publicado: (2021)

Left Atrial Dysfunction as Marker of Arrhythmic Events in Patients with Hypertrophic Cardiomyopathy
por: Candan, Özkan, et al.
Publicado: (2022)

Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Longitudinal Changes of Left Atrial Volume Index as a Prognosticator in Hypertrophic Cardiomyopathy
por: Kim, Sungseek, et al.
Publicado: (2023)

Mitochondrial Cardiomyopathy Presenting as Dilated Phase of Hypertrophic Cardiomyopathy Diagnosed with Histological and Genetic Analyses
por: Kuno, Toshiki, et al.
Publicado: (2017)

Hypertrophic cardiomyopathy masquerading as infiltrative restrictive cardiomyopathy and refractory congestive failure-resolution with catheter ablation of atrial flutter – A case report
por: Kalavakolanu, Sharada Sivaram
Publicado: (2015)

Acute myocardial infarction occurring after hypertrophic obstructive cardiomyopathy with paroxysmal atrial fibrillation: a case report
por: Fang, Dingfeng, et al.
Publicado: (2022)

Changes in left atrial deformation in hypertrophic cardiomyopathy: Evaluation by vector velocity imaging
por: Badran, Hala Mahfouz, et al.
Publicado: (2013)

Cardiac MRI predictors for development of atrial fibrillation or flutter in patients with hypertrophic cardiomyopathy
por: She, Helen Hoi Lam, et al.
Publicado: (2015)

Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2021)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Reply to Letter to the Editor: “Atrial Function Assessment in High-Risk Hypertrophic Cardiomyopathy”
por: Candan, Özkan, et al.
Publicado: (2023)

Impact of catheter ablation on atrial fibrillation burden and symptoms in patients with hypertrophic cardiomyopathy
por: Ahluwalia, N, et al.
Publicado: (2023)

Characterization, Pathogenesis, and Clinical Implications of Inflammation‐Related Atrial Myopathy as an Important Cause of Atrial Fibrillation
por: Packer, Milton
Publicado: (2020)

A Rare Cause of Syncope: Apical Biventricular Hypertrophic Cardiomyopathy Complicated by Atrial Flutter
por: Cinar, Tufan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fq9ljkakh40n81lribl0deatl6